Read + Share
Amedeo Smart
Independent Medical Education
Larkin HD. FDA Expands Empagliflozin Heart Failure Indication. JAMA 2022;327:1219.PMID: 35380600
Email
LinkedIn
Facebook
Twitter
Privacy Policy